摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methyl-7-ethyl-coumarin | 101999-44-4

中文名称
——
中文别名
——
英文名称
4-methyl-7-ethyl-coumarin
英文别名
7-ethyl-4-methyl-2H-1-benzopyran-2-one;2H-1-Benzopyran-2-one, 7-ethyl-4-methyl-;7-ethyl-4-methylchromen-2-one
4-methyl-7-ethyl-coumarin化学式
CAS
101999-44-4
化学式
C12H12O2
mdl
MFCD03305869
分子量
188.226
InChiKey
KBAOONDOLHDLDN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    320.3±31.0 °C(Predicted)
  • 密度:
    1.121±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    3-乙基苯酚乙酰乙酸乙酯硫酸 作用下, 反应 48.0h, 以77%的产率得到4-methyl-7-ethyl-coumarin
    参考文献:
    名称:
    Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones
    摘要:
    A number of 4,7-disubstituted benzopyran-2-ones were synthesized and evaluated for crude rat lens aldose reductase inhibitory activity. Substituents on position 4 included CH3, CO2H, CH2CO2H, CH = CHCO2H, and CH2CH2CO2H. The aromatic substituents included OH, OCH3, OCOCH3, CH2CH3, and Cl. Also included in the study were 3-oxo-3H-naphtho[2,1-b]pyran-1-acetic, 2-oxo-2H-naphtho[1,2-b]pyran-4-acetic, and 1-naphthylacetic acids. The benzopyran and naphthopyran derivatives were prepared by the classical von Pechmann reaction. General structure-activity relationships reveal that optimal enzyme inhibitory activity is displayed by those compounds possessing the acetic acid moiety. For example, the most potent derivative, 3-oxo-3H-naphtho[2,1-b]pyran-1-acetic acid with an IC50 of 0.020 microM, is as potent as sorbinil (IC50 = 0.017 microM) in the crude rat lens aldose reductase assay.
    DOI:
    10.1021/jm00156a031
点击查看最新优质反应信息

文献信息

  • CHEMOENZYMATIC SYNTHESIS OF HEPARIN AND HEPARAN SULFATE ANALOGS
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20140235575A1
    公开(公告)日:2014-08-21
    The present invention provides a one-pot multi-enzyme method for preparing UDP-sugars from simple sugar starting materials. The invention also provides a one-pot multi-enzyme method for preparing oligosaccharides from simple sugar starting materials.
    本发明提供了一种一锅多酶法,用于从简单糖起始材料制备UDP糖。该发明还提供了一种一锅多酶法,用于从简单糖起始材料制备寡糖。
  • Compositions useful as inhibitors of voltage-gated sodium channels
    申请人:Gonzalez E. Jesus
    公开号:US20060025415A1
    公开(公告)日:2006-02-02
    The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
  • 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS
    申请人:Sugimoto Tomohiro
    公开号:US20110237784A1
    公开(公告)日:2011-09-29
    A novel 10a-azalide compound crosslinked at the 10a- and 12-positions, which is represented by the following formula, and is effective on even Hemophilus influenzae , or erythromycin resistant bacteria (e.g., resistant pneumococci and streptococci).
    一种新型的10a-azalide化合物,其在10a-和12-位置交联,化学式如下,并且对于Hemophilus influenzae,或者对红霉素产生耐药性的细菌(例如耐药性肺炎球菌和链球菌)具有有效性。
  • COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS
    申请人:Gonzalez, III Jesus E.
    公开号:US20120238578A1
    公开(公告)日:2012-09-20
    The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及用作电压门控钠通道抑制剂的化合物。本发明还提供了包括本发明化合物的药学上可接受的组合物以及使用这些组合物治疗各种疾病的方法。
  • Compounds from invasive Salvinias and methods of using the same
    申请人:STEPHEN F. AUSTIN STATE UNIVERSITY
    公开号:US10464963B2
    公开(公告)日:2019-11-05
    In some embodiments, the compositions and methods relate to compounds isolated from plants in the Salviniaceae family, pharmaceutical compositions comprising the same, and methods of using the same.
    在某些实施方案中,组合物和方法涉及从沙棘科植物中分离的化合物、包含这些化合物的药物组合物以及使用这些化合物的方法。
查看更多